SCHEMBL3321369

SCHEMBL3321369

Fc1ccc(Oc2cc(F)ccc2OC[C@H]2CCCNC2)c(Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K1 Q02750 2/20 0.43
SLC6A4 P31645 3/20 0.43
HTR6 P50406 1/20 0.43
SLC6A2 P23975 3/20 0.42
SLC6A3 Q01959 3/20 0.42
CYP2D6 P10635 1/20 0.42
SCN9A Q15858 1/20 0.42
IKBKB O14920 1/20 0.41
CHUK O15111 1/20 0.41
MGLL Q99685 5/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
HTR2C P28335 2/20 0.39
HTR2B P41595 2/20 0.39
F2 P00734 1/20 0.39
PLG P00747 1/20 0.39
PLAU P00749 1/20 0.39
PIM1 P11309 1/20 0.39
PIM2 Q9P1W9 1/20 0.39
ROCK2 O75116 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3321373 1.00 MAP2K1 (0.43) MAP2K1SLC6A4HTR6SLC6A2SLC6A3
SCHEMBL3325058 0.87 SLC6A2 (0.45) MAP2K1SLC6A4SLC6A2SLC6A3CYP2D6
SCHEMBL3329880 0.87 SLC6A2 (0.45) MAP2K1SLC6A4SLC6A2SLC6A3CYP2D6
SCHEMBL3325733 0.86 SLC6A2 (0.51) MAP2K1SLC6A4SLC6A2SLC6A3CYP2D6
SCHEMBL3325140 0.86 MAP2K1 (0.41) MAP2K1SLC6A4SLC6A2SLC6A3CYP2D6
SCHEMBL3329940 0.86 SLC6A2 (0.51) MAP2K1SLC6A4SLC6A2SLC6A3CYP2D6
SCHEMBL3325149 0.86 MAP2K1 (0.41) MAP2K1SLC6A4SLC6A2SLC6A3CYP2D6
SCHEMBL3324991 0.85 SLC6A4 (0.48) SLC6A4HTR6SLC6A2SLC6A3CYP2D6
SCHEMBL3324998 0.85 SLC6A4 (0.48) SLC6A4HTR6SLC6A2SLC6A3CYP2D6
SCHEMBL3324811 0.83 IKBKB (0.50) MAP2K1SLC6A4SLC6A2SLC6A3CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100120858-A1 Piperidine Derivatives PFIZER INC. 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120858-A1 Piperidine Derivatives P2RX5, P2RX7, P2RX1 MAP2K1 4782/4885SLC6A4 1898/4885HTR6 832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.